Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-016856
Filing Date
2019-06-13
Accepted
2019-06-13 17:09:43
Documents
2
Period of Report
2019-06-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4023
2 EX-24 DOCUMENT attachment1.htm EX-24 4514
  Complete submission text file 0000899243-19-016856.txt   10035
Mailing Address SOLAZYME, INC. 225 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address
CLARK IAN T (Reporting) CIK: 0001336504 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38537 | Film No.: 19896811

Mailing Address ONE KENDALL SQUARE BLDG. 300, SUITE 201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 300, SUITE 201 CAMBRIDGE MA 02139 7819626030
AVROBIO, Inc. (Issuer) CIK: 0001681087 (see all company filings)

EIN.: 810710585 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)